Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy

Hay, KA; Gauthier, J; Hirayama, AV; Voutsinas, JM; Wu, Q; Li, D; Gooley, TA; Cherian, S; Chen, XY; Pender, BS; Hawkins, RM; Vakil, A; Steinmetz, RN; Schoch, G; Chapuis, AG; Till, BG; Kiem, HP; Ramos, JD; Shadman, M; Cassaday, RD; Acharya, UH; Riddell

Hay, KA (reprint author), British Columbia Canc Res Ctr, 675 West 10th Ave, Vancouver, BC V5Z 1L3, Canada.

BLOOD, 2019; 133 (15): 1652

Abstract

Autologous T cells engineered to express a CD19-specific chimeric antigen receptor (CAR) have produced impressive minimal residual disease-negative (M......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索